Boston Scientific Corporation (BVMF:B1SX34)

Market Cap	585.14B -34.9%
Revenue (ttm)	110.57B +19.9%
Net Income	15.96B +56.4%
EPS	10.69 +55.2%
Shares Out	n/a
PE Ratio	36.66
Forward PE	22.03
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51
Average Volume	65
Open	393.09
Previous Close	381.78
Day's Range	393.09 - 393.09
52-Week Range	378.57 - 606.06
Beta	0.66
RSI	34.12
Earnings Date	Feb 4, 2026

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatogra...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 59,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: B1SX34

Financial Performance

In 2025, Boston Scientific's revenue was $20.07 billion, an increase of 19.87% compared to the previous year's $16.75 billion. Earnings were $2.90 billion, an increase of 56.40%.

Financial numbers in USD